Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli - PubMed (original) (raw)
Clinical Trial
Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli
M L Clements et al. Antimicrob Agents Chemother. 1981 Jul.
Abstract
In vitro and animal experiments indicated that lactobacilli might prevent Escherichia coli from colonizing the intestine and may produce substances counteracting enterotoxin. Lactinex, a commercial preparation of dried Lactobacillus acidophilus and L. bulgaricus, is marketed for uncomplicated diarrhea. Preliminary experiments in nonfasting volunteers indicated that lactobacilli in this preparation colonized the small intestine for up to 6 h. To evaluate the protective efficacy of Lactinex, a double-blind randomized study was carried out in which 48 volunteers (23 receiving Lactinex and 25 receiving placebos) were challenged with E. coli strains that produced heat-stable or heat-labile enterotoxins or both. No significant differences between the two groups were noted with respect to attack rate, incubation period, duration of diarrhea, volume and number of liquid stools, and coproculture yields. These data suggest that this lactobacillus preparations does not prevent or alter the course of enterotoxigenic E. coli diarrhea in adults. Lack of efficacy occurred despite efforts to maximize small bowel colonization, including administration of Lactinex in milk and in a 6-hour-interval regimen during 36 h before and 96 h after challenge.
Similar articles
- A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea.
Tankanow RM, Ross MB, Ertel IJ, Dickinson DG, McCormick LS, Garfinkel JF. Tankanow RM, et al. DICP. 1990 Apr;24(4):382-4. doi: 10.1177/106002809002400408. DICP. 1990. PMID: 2109432 Clinical Trial. - Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli.
Tacket CO, Losonsky G, Link H, Hoang Y, Guesry P, Hilpert H, Levine MM. Tacket CO, et al. N Engl J Med. 1988 May 12;318(19):1240-3. doi: 10.1056/NEJM198805123181904. N Engl J Med. 1988. PMID: 3283555 Clinical Trial. - Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation.
Gotz V, Romankiewicz JA, Moss J, Murray HW. Gotz V, et al. Am J Hosp Pharm. 1979 Jun;36(6):754-7. Am J Hosp Pharm. 1979. PMID: 111546 Clinical Trial. - [New approaches in the prevention of diarrhea caused by Escherichia coli].
Cravioto A. Cravioto A. Bol Med Hosp Infant Mex. 1989 Nov;46(11):736-42. Bol Med Hosp Infant Mex. 1989. PMID: 2698638 Review. Spanish. - Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans.
Zhang W, Sack DA. Zhang W, et al. Expert Rev Vaccines. 2012 Jun;11(6):677-94. doi: 10.1586/erv.12.37. Expert Rev Vaccines. 2012. PMID: 22873126 Review.
Cited by
- Role of probiotics in prevention and treatment of enteric infections: a comprehensive review.
Iqbal Z, Ahmed S, Tabassum N, Bhattacharya R, Bose D. Iqbal Z, et al. 3 Biotech. 2021 May;11(5):242. doi: 10.1007/s13205-021-02796-7. Epub 2021 Apr 27. 3 Biotech. 2021. PMID: 33968585 Free PMC article. Review. - Refinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccines.
Harro C, Chakraborty S, Feller A, DeNearing B, Cage A, Ram M, Lundgren A, Svennerholm AM, Bourgeois AL, Walker RI, Sack DA. Harro C, et al. Clin Vaccine Immunol. 2011 Oct;18(10):1719-27. doi: 10.1128/CVI.05194-11. Epub 2011 Aug 18. Clin Vaccine Immunol. 2011. PMID: 21852546 Free PMC article. Clinical Trial. - Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.
Goldenberg JZ, Yap C, Lytvyn L, Lo CK, Beardsley J, Mertz D, Johnston BC. Goldenberg JZ, et al. Cochrane Database Syst Rev. 2017 Dec 19;12(12):CD006095. doi: 10.1002/14651858.CD006095.pub4. Cochrane Database Syst Rev. 2017. PMID: 29257353 Free PMC article. Review. - Volunteer challenge with enterotoxigenic Escherichia coli that express intestinal colonization factor fimbriae CS17 and CS19.
McKenzie R, Porter CK, Cantrell JA, Denearing B, O'Dowd A, Grahek SL, Sincock SA, Woods C, Sebeny P, Sack DA, Tribble DR, Bourgeois AL, Savarino SJ. McKenzie R, et al. J Infect Dis. 2011 Jul 1;204(1):60-4. doi: 10.1093/infdis/jir220. J Infect Dis. 2011. PMID: 21628659 Free PMC article. - In vitro antibacterial effect of yogurt on Escherichia coli.
Kotz CM, Peterson LR, Moody JA, Savaiano DA, Levitt MD. Kotz CM, et al. Dig Dis Sci. 1990 May;35(5):630-7. doi: 10.1007/BF01540412. Dig Dis Sci. 1990. PMID: 2185003
References
- J Pediatr. 1974 Feb;84(2):261-2 - PubMed
- J Bacteriol. 1953 Jun;65(6):681-99 - PubMed
- Infect Immun. 1975 Sep;12(3):656-67 - PubMed
- N Engl J Med. 1975 May 1;292(18):933-6 - PubMed
- Am J Clin Nutr. 1981 Apr;34(4):514-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical